Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows – News-Medical.net
Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study showsNews-Medical.netThe new immunotherapy treatments aim to block the activity of certain proteins that inhibit the immune system. In lung cancer, this therapeut… Continue reading
